NicErase-IA: Started second Phase III trial

DynaGen Inc. (DYGN) Product: NicErase-IA parenteral formulation of L-lobeline Indication: Nicotine withdrawal in hospitalized patients restricted from smoking Status: Started second Phase III trial i...